{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T23:09:48Z","timestamp":1773011388502,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004243","name":"Prinses Beatrix Spierfonds","doi-asserted-by":"publisher","award":["W.OR15-10"],"award-info":[{"award-number":["W.OR15-10"]}],"id":[{"id":"10.13039\/501100004243","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>In Pompe disease, an inherited metabolic muscle disorder, severe diaphragmatic weakness often occurs. Enzyme replacement treatment is relatively ineffective for respiratory function, possibly because of irreversible damage to the diaphragm early in the disease course. Mildly impaired diaphragmatic function may not be recognized by spirometry, which is commonly used to study respiratory function. In this cross-sectional study, we aimed to identify early signs of diaphragmatic weakness in Pompe patients using chest MRI.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Pompe patients covering the spectrum of disease severity, and sex and age matched healthy controls were prospectively included and studied using spirometry-controlled sagittal MR images of both mid-hemidiaphragms during forced inspiration. The motions of the diaphragm and thoracic wall were evaluated by measuring thoracic cranial-caudal and anterior\u2013posterior distance ratios between inspiration and expiration. The diaphragm shape was evaluated by measuring the height of the diaphragm curvature. We used multiple linear regression analysis to compare different groups.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We included 22 Pompe patients with decreased spirometry results (forced vital capacity in supine position &lt;\u200980% predicted); 13 Pompe patients with normal spirometry results (forced vital capacity in supine position \u2265\u200980% predicted) and 18 healthy controls. The mean cranial-caudal ratio was only 1.32 in patients with decreased spirometry results, 1.60 in patients with normal spirometry results and 1.72 in healthy controls (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). Anterior\u2013posterior ratios showed no significant differences. The mean height ratios of the diaphragm curvature were 1.41 in patients with decreased spirometry results, 1.08 in patients with normal spirometry results and 0.82 in healthy controls (<jats:italic>p<\/jats:italic>\u2009=\u20090.001), indicating an increased curvature of the diaphragm during inspiration in Pompe patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Even in early-stage Pompe disease, when spirometry results are still within normal range, the motion of the diaphragm is already reduced and the shape is more curved during inspiration. MRI can be used to detect early signs of diaphragmatic weakness in patients with Pompe disease, which might help to select patients for early intervention to prevent possible irreversible damage to the diaphragm.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13023-020-01627-x","type":"journal-article","created":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T12:03:47Z","timestamp":1610021027000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Chest MRI to diagnose early diaphragmatic weakness in Pompe disease"],"prefix":"10.1186","volume":"16","author":[{"given":"Laurike","family":"Harlaar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierluigi","family":"Ciet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gijs","family":"van Tulder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice","family":"Pittaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harmke A.","family":"van Kooten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadine A. M. E.","family":"van der Beek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"Brusse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr A.","family":"Wielopolski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marleen","family":"de Bruijne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ans T.","family":"van der Ploeg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harm A. W. M.","family":"Tiddens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pieter A.","family":"van Doorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,7]]},"reference":[{"key":"1627_CR1","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/1750-1172-7-88","volume":"7","author":"NA van der Beek","year":"2012","unstructured":"van der Beek NA, de Vries JM, Hagemans ML, Hop WC, Kroos MA, Wokke JH, et al. Clinical features and predictors for disease natural progression in adults with Pompe disease: a nationwide prospective observational study. Orphanet J Rare Dis. 2012;7:88.","journal-title":"Orphanet J Rare Dis"},{"issue":"9646","key":"1627_CR2","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/S0140-6736(08)61555-X","volume":"372","author":"AT van der Ploeg","year":"2008","unstructured":"van der Ploeg AT, Reuser AJ. Pompe\u2019s disease. Lancet. 2008;372(9646):1342\u201353.","journal-title":"Lancet"},{"issue":"2","key":"1627_CR3","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1542\/peds.112.2.332","volume":"112","author":"HM van den Hout","year":"2003","unstructured":"van den Hout HM, Hop W, van Diggelen OP, Smeitink JA, Smit GP, Poll-The BT, et al. The natural course of infantile Pompe\u2019s disease: 20 original cases compared with 133 cases from the literature. Pediatrics. 2003;112(2):332\u201340.","journal-title":"Pediatrics"},{"issue":"1","key":"1627_CR4","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1053\/apmr.2001.18053","volume":"82","author":"C Fromageot","year":"2001","unstructured":"Fromageot C, Lofaso F, Annane D, Falaize L, Lejaille M, Clair B, et al. Supine fall in lung volumes in the assessment of diaphragmatic weakness in neuromuscular disorders. Arch Phys Med Rehabil. 2001;82(1):123\u20138.","journal-title":"Arch Phys Med Rehabil"},{"issue":"1\u20132","key":"1627_CR5","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ymgme.2011.06.012","volume":"104","author":"NA van der Beek","year":"2011","unstructured":"van der Beek NA, van Capelle CI, van der Velden-van Etten KI, Hop WC, van den Berg B, Reuser AJ, et al. Rate of progression and predictive factors for pulmonary outcome in children and adults with Pompe disease. Mol Genet Metab. 2011;104(1\u20132):129\u201336.","journal-title":"Mol Genet Metab"},{"issue":"15","key":"1627_CR6","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1056\/NEJMoa0909859","volume":"362","author":"AT van der Ploeg","year":"2010","unstructured":"van der Ploeg AT, Clemens PR, Corzo D, Escolar DM, Florence J, Groeneveld GJ, et al. A randomized study of alglucosidase alfa in late-onset Pompe\u2019s disease. N Engl J Med. 2010;362(15):1396\u2013406.","journal-title":"N Engl J Med"},{"issue":"4","key":"1627_CR7","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.ymgme.2016.01.013","volume":"117","author":"KM Stepien","year":"2016","unstructured":"Stepien KM, Hendriksz CJ, Roberts M, Sharma R. Observational clinical study of 22 adult-onset Pompe disease patients undergoing enzyme replacement therapy over 5years. Mol Genet Metab. 2016;117(4):413\u20138.","journal-title":"Mol Genet Metab"},{"issue":"5","key":"1627_CR8","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1007\/s00415-011-6293-5","volume":"259","author":"C Angelini","year":"2012","unstructured":"Angelini C, Semplicini C, Ravaglia S, Bembi B, Servidei S, Pegoraro E, et al. Observational clinical study in juvenile-adult glycogenosis type 2 patients undergoing enzyme replacement therapy for up to 4 years. J Neurol. 2012;259(5):952\u20138.","journal-title":"J Neurol"},{"key":"1627_CR9","doi-asserted-by":"crossref","unstructured":"Kuperus E, Kruijshaar ME, Wens SCA, de Vries JM, Favejee MM, van der Meijden JC, et al. Long-term benefit of enzyme replacement therapy in Pompe disease: a 5-year prospective study. Neurology. 2017.","DOI":"10.1212\/WNL.0000000000004711"},{"issue":"19","key":"1627_CR10","doi-asserted-by":"publisher","first-page":"e1756","DOI":"10.1212\/WNL.0000000000008441","volume":"93","author":"L Harlaar","year":"2019","unstructured":"Harlaar L, Hogrel JY, Perniconi B, Kruijshaar ME, Rizopoulos D, Taouagh N, et al. Large variation in effects during 10 years of enzyme therapy in adults with Pompe disease. Neurology. 2019;93(19):e1756\u201367.","journal-title":"Neurology"},{"issue":"6","key":"1627_CR11","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1111\/ene.13285","volume":"24","author":"AT van der Ploeg","year":"2017","unstructured":"van der Ploeg AT, Kruijshaar ME, Toscano A, Laforet P, Angelini C, Lachmann RH, et al. European consensus for starting and stopping enzyme replacement therapy in adult patients with Pompe disease: a 10-year experience. Eur J Neurol. 2017;24(6):768-e31.","journal-title":"Eur J Neurol"},{"issue":"2","key":"1627_CR12","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.nmd.2015.11.009","volume":"26","author":"EM Johnson","year":"2016","unstructured":"Johnson EM, Roberts M, Mozaffar T, Young P, Quartel A, Berger KI. Pulmonary function tests (maximum inspiratory pressure, maximum expiratory pressure, vital capacity, forced vital capacity) predict ventilator use in late-onset Pompe disease. Neuromuscul Disord. 2016;26(2):136\u201345.","journal-title":"Neuromuscul Disord"},{"issue":"8","key":"1627_CR13","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.nmd.2016.05.018","volume":"26","author":"KI Berger","year":"2016","unstructured":"Berger KI, Chan Y, Rom WN, Oppenheimer BW, Goldring RM. Progression from respiratory dysfunction to failure in late-onset Pompe disease. Neuromuscul Disord. 2016;26(8):481\u20139.","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"1627_CR14","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.nmd.2017.11.010","volume":"28","author":"L Harlaar","year":"2018","unstructured":"Harlaar L, Ciet P, van der Ploeg AT, Brusse E, van der Beek N, Wielopolski PA, et al. Imaging of respiratory muscles in neuromuscular disease: a review. Neuromuscul Disord. 2018;28(3):246\u201356.","journal-title":"Neuromuscul Disord"},{"key":"1627_CR15","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12890-015-0058-3","volume":"15","author":"SC Wens","year":"2015","unstructured":"Wens SC, Ciet P, Perez-Rovira A, Logie K, Salamon E, Wielopolski P, et al. Lung MRI and impairment of diaphragmatic function in Pompe disease. BMC Pulm Med. 2015;15:54.","journal-title":"BMC Pulm Med"},{"issue":"3","key":"1627_CR16","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.ymgme.2013.06.023","volume":"110","author":"M Gaeta","year":"2013","unstructured":"Gaeta M, Barca E, Ruggeri P, Minutoli F, Rodolico C, Mazziotti S, et al. Late-onset Pompe disease (LOPD): correlations between respiratory muscles CT and MRI features and pulmonary function. Mol Genet Metab. 2013;110(3):290\u20136.","journal-title":"Mol Genet Metab"},{"issue":"11","key":"1627_CR17","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.nmd.2015.09.003","volume":"25","author":"M Gaeta","year":"2015","unstructured":"Gaeta M, Musumeci O, Mondello S, Ruggeri P, Montagnese F, Cucinotta M, et al. Clinical and pathophysiological clues of respiratory dysfunction in late-onset Pompe disease: new insights from a comparative study by MRI and respiratory function assessment. Neuromuscular Disord. 2015;25(11):852\u20138.","journal-title":"Neuromuscular Disord"},{"issue":"7","key":"1627_CR18","doi-asserted-by":"publisher","first-page":"e0158912","DOI":"10.1371\/journal.pone.0158912","volume":"11","author":"K Mogalle","year":"2016","unstructured":"Mogalle K, Perez-Rovira A, Ciet P, Wens SC, van Doorn PA, Tiddens HA, et al. Quantification of diaphragm mechanics in pompe disease using dynamic 3D MRI. PLoS ONE. 2016;11(7):e0158912.","journal-title":"PLoS ONE"},{"key":"1627_CR19","doi-asserted-by":"crossref","unstructured":"American Thoracic Society\/European Respiratory Society. ATS\/ERS Statement on respiratory muscle testing. Am J Respir Crit Care Med. 2002;166(4):518\u2013624.","DOI":"10.1164\/rccm.166.4.518"},{"issue":"6","key":"1627_CR20","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1183\/09031936.00080312","volume":"40","author":"PH Quanjer","year":"2012","unstructured":"Quanjer PH, Stanojevic S, Cole TJ, Baur X, Hall GL, Culver BH, et al. Multi-ethnic reference values for spirometry for the 3\u201395-year age range: the global lung function 2012 equations. Eur Respir J. 2012;40(6):1324\u201343.","journal-title":"Eur Respir J"},{"issue":"7","key":"1627_CR21","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1136\/thx.39.7.535","volume":"39","author":"SH Wilson","year":"1984","unstructured":"Wilson SH, Cooke NT, Edwards RH, Spiro SG. Predicted normal values for maximal respiratory pressures in caucasian adults and children. Thorax. 1984;39(7):535\u20138.","journal-title":"Thorax"},{"issue":"3","key":"1627_CR22","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.neuroimage.2006.01.015","volume":"31","author":"PA Yushkevich","year":"2006","unstructured":"Yushkevich PA, Piven J, Hazlett HC, Smith RG, Ho S, Gee JC, et al. User-guided 3D active contour segmentation of anatomical structures: significantly improved efficiency and reliability. Neuroimage. 2006;31(3):1116\u201328.","journal-title":"Neuroimage"},{"issue":"2","key":"1627_CR23","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jcm.2016.02.012","volume":"15","author":"TK Koo","year":"2016","unstructured":"Koo TK, Li MY. A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med. 2016;15(2):155\u201363.","journal-title":"J Chiropr Med"},{"key":"1627_CR24","doi-asserted-by":"crossref","unstructured":"Barnard AM, Lott DJ, Batra A, Triplett WT, Forbes SC, Riehl SL, et al. Imaging respiratory muscle quality and function in Duchenne muscular dystrophy. J Neurol. 2019.","DOI":"10.1007\/s00415-019-09481-z"},{"issue":"1","key":"1627_CR25","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13023-019-1037-1","volume":"14","author":"M Confalonieri","year":"2019","unstructured":"Confalonieri M, Vitacca M, Scala R, Polverino M, Sabato E, Crescimanno G, et al. Is early detection of late-onset Pompe disease a pneumologist\u2019s affair? A lesson from an Italian screening study. Orphanet J Rare Dis. 2019;14(1):62.","journal-title":"Orphanet J Rare Dis"},{"key":"1627_CR26","doi-asserted-by":"crossref","unstructured":"Guimaraes MJ, Winck JC, Conde B, Mineiro A, Raposo M, Moita J, et al. Prevalence of late-onset pompe disease in Portuguese patients with diaphragmatic paralysis\u2014DIPPER study. Rev Port Pneumol (2006). 2017;23(4):208\u201315.","DOI":"10.1016\/j.rppnen.2017.02.004"},{"key":"1627_CR27","unstructured":"Gayan-Ramirez G, Decramer M. The Respiratory Muscles. In: Grippi MA, Elias JA, Fishman JA, Kotloff RM, Pack AI, Senior RM, et al., editors. Fishman's pulmonary diseases and disorders, 5e. New York, NY: McGraw-Hill Education; 2015."},{"issue":"10","key":"1627_CR28","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1056\/NEJMra1007236","volume":"366","author":"FD McCool","year":"2012","unstructured":"McCool FD, Tzelepis GE. Dysfunction of the diaphragm. N Engl J Med. 2012;366(10):932\u201342.","journal-title":"N Engl J Med"},{"issue":"5","key":"1627_CR29","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1183\/09031936.93.04050587","volume":"4","author":"M Mizuno","year":"1991","unstructured":"Mizuno M. Human respiratory muscles: fibre morphology and capillary supply. Eur Respir J. 1991;4(5):587\u2013601.","journal-title":"Eur Respir J"},{"issue":"9","key":"1627_CR30","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1136\/thx.2003.009894","volume":"59","author":"B Polla","year":"2004","unstructured":"Polla B, D\u2019Antona G, Bottinelli R, Reggiani C. Respiratory muscle fibres: specialisation and plasticity. Thorax. 2004;59(9):808\u201317.","journal-title":"Thorax"},{"issue":"5","key":"1627_CR31","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1007\/s10545-012-9541-7","volume":"36","author":"LE van den Berg","year":"2013","unstructured":"van den Berg LE, Drost MR, Schaart G, de Laat J, van Doorn PA, van der Ploeg AT, et al. Muscle fiber-type distribution, fiber-type-specific damage, and the Pompe disease phenotype. J Inherit Metab Dis. 2013;36(5):787\u201394.","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"1627_CR32","first-page":"45","volume":"26","author":"N Raben","year":"2007","unstructured":"Raben N, Roberts A, Plotz PH. Role of autophagy in the pathogenesis of Pompe disease. Acta Myol. 2007;26(1):45\u20138.","journal-title":"Acta Myol"},{"issue":"8","key":"1627_CR33","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1007\/s10072-020-04316-6","volume":"41","author":"P Ruggeri","year":"2020","unstructured":"Ruggeri P, Lo Monaco L, Musumeci O, Tavilla G, Gaeta M, Caramori G, et al. Ultrasound assessment of diaphragm function in patients with late-onset Pompe disease. Neurol Sci. 2020;41(8):2175\u201384.","journal-title":"Neurol Sci"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-020-01627-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-020-01627-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-020-01627-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,10]],"date-time":"2022-12-10T22:03:38Z","timestamp":1670709818000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-020-01627-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,7]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1627"],"URL":"https:\/\/doi.org\/10.1186\/s13023-020-01627-x","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,7]]},"assertion":[{"value":"5 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The protocol was approved by the Medical Ethical Committee at our hospital (MEC-2007-103, amendment 7). All participants provided written informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"NAMEB received funding for research and as advisor or speaker from Sanofi-Genzyme, under agreements with Erasmus MC University Medical Center. ATP received funding for research and\/or clinical trials and as advisor or speaker from Amicus, Sanofi-Genzyme, Ultragenix, Spark Therapeutics, Audentes, Biomarin, Shire, Ciesi, Sarepta under agreements with Erasmus MC University Medical Center and the relevant industry. HAWMT received unconditional research grants outside the submitted work from Roche, Novartis, CFF, Vertex, Chiesi, Vectura, and Gilead and participated in the last 5\u00a0years in expert panels for Vertex and Gilead. All financial aspects for the grants are handled by Sophia Research BV. All other authors report no relevant disclosures.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21"}}